In agreement, studies indicate that RBP4 can be considered a biomarker of glomerular diseases, such as diabetic nephropathy [41,42], and proximal tubulopathies, such as Falconi syndrome [42]. This evidence concerns the gene RBP4 and diabetic kidney disease.